Tarsus Pharmaceuticals Ratios (2020-2025) | TARS

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 96.12%96.65%94.76%107.10%93.88%96.58%96.00%100.00%79.85%90.70%94.01%92.64%93.26%92.58%93.35%93.92%93.00%
EBT Margin 32.07%33.11%-1,265.89%-4,271.01%-3,680.33%-35.81%-136.26%-933.72%-2,081.93%-324.72%-128.74%-76.64%-48.81%-34.76%-31.96%-19.67%-10.69%
EBIT Margin 32.05%33.07%-1,266.53%-4,274.56%-3,621.71%-34.20%-150.61%-998.08%-2,187.87%-339.94%-136.47%-81.60%-52.29%-36.77%-33.55%-21.61%-12.24%
EBITDA Margin 31.04%28.82%-1,265.89%-4,393.79%-3,754.73%-37.59%-136.63%-936.60%-2,091.56%-320.40%-129.62%-81.84%-47.59%-35.06%-32.19%-19.86%-10.39%
Operating Margin 32.05%33.07%-1,266.53%-4,274.56%-3,621.71%-34.20%-150.61%-998.08%-2,187.87%-339.94%-136.47%-81.60%-52.29%-36.77%-33.55%-21.61%-12.24%
Net Margin 31.14%32.97%-1,238.39%-4,286.98%-3,680.52%-35.81%-136.26%-933.72%-2,081.93%-324.72%-128.74%-76.64%-48.81%-34.76%-31.96%-19.67%-10.69%
FCF Margin -35.80%93.27%563.79%-3,667.16%-2,865.86%-28.68%-110.01%-892.40%-1,749.71%-300.82%-137.48%-37.84%-18.57%-33.51%-27.12%-29.60%13.77%
Efficiency
Inventory Average 1.56M3.57M3.12M2.52M2.73M2.66M3.29M3.85M
Assets Average 132.08M182.96M198.70M196.93M184.66M180.19M217.16M244.65M232.16M219.54M200.07M228.63M266.91M307.38M363.06M376.57M376.65M438.87M497.87M514.78M
Equity Average -9.50M-14.43M74.08M174.61M187.85M185.81M172.94M157.96M185.35M212.07M197.76M183.15M160.57M180.70M205.33M236.10M263.73M244.87M231.01M283.50M337.54M333.85M
Invested Capital -7.96M-11.04M-17.83M165.98M183.23M192.47M179.14M166.73M168.38M240.77M221.98M212.33M197.92M172.34M243.37M226.81M305.14M323.82M309.19M296.38M414.44M404.74M407.36M
Asset Utilization Ratio 0.180.280.290.310.130.080.070.110.130.060.060.070.140.230.340.490.530.590.71
Leverage & Solvency
Interest Coverage Ratio -61.78-9.60-36.19-21.76-36.48-40.27-47.71-44.94-38.34-15.79-10.29-10.56-11.88-9.90-6.41
Debt to Equity 0.130.090.100.100.140.170.140.150.110.280.300.320.210.220.22
Debt Ratio 0.110.080.080.090.120.130.110.110.090.190.190.190.140.150.14
Equity Ratio -0.190.970.940.950.940.930.820.880.860.850.820.780.800.740.790.670.630.600.680.670.63
Times Interest Earned -61.78-9.60-36.19-21.76-36.48-40.27-47.71-44.94-38.34-15.79-10.29-10.56-11.88-9.90-6.41
Valuation
Enterprise Value -55.89M-53.13M-86.35M-168.15M-156.20M-176.74M-183.80M-171.81M-175.30M-245.40M-226.57M-217.03M-201.22M-178.23M-246.88M-227.44M-298.52M-323.58M-316.95M-291.38M-407.92M-381.14M-401.84M
Return Ratios
Return on Sales 0.31%0.33%-12.38%-42.87%-36.81%-0.36%-3.85%-1.36%-9.34%-7.27%-20.82%-3.25%-1.29%-0.77%-0.49%-0.35%-0.32%-0.20%-0.11%
Return on Capital Employed -0.21%-0.08%-0.02%-0.05%-0.07%-0.25%-0.27%-0.27%-0.29%-0.33%-0.52%-0.55%-0.62%-0.59%-0.50%-0.45%-0.41%-0.31%-0.24%-0.22%
Return on Invested Capital -0.36%-0.08%-0.02%-0.05%-0.07%-0.25%-0.27%-0.27%-0.29%-0.33%-0.52%
Return on Assets -0.20%-0.08%-0.02%-0.05%-0.07%-0.24%-0.25%-0.25%-0.26%-0.30%-0.45%-0.47%-0.51%-0.48%-0.41%-0.35%-0.30%-0.23%-0.18%-0.16%
Return on Equity -0.36%-0.08%-0.02%-0.05%-0.07%-0.27%-0.30%-0.29%-0.31%-0.35%-0.57%-0.59%-0.66%-0.63%-0.56%-0.54%-0.49%-0.36%-0.27%-0.24%